Clinical Trials Sponsored by Parker Medical

Total 58286 results

Warner Chilcott

Completed

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Acne Vulgaris

United States
Warner Chilcott

Completed

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis

Ulcerative Colitis

Poland, United States, Croatia, Romania, Canada
Warner Chilcott

Completed

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Postmenopausal Women

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction I

Erectile Dysfunction

United States
Warner Chilcott

Completed

Effect of Udenafil on Spermatogenesis

Erectile Dysfunction | Spermatogenesis

United States
Warner Chilcott

Completed

Study of Bleeding With Extended Administration of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Terminated

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Colombia
Warner Chilcott

Completed

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women (VENUS)

Postmenopausal Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Postmenopausal Osteoporosis

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction II

Erectile Dysfunction

United States
Warner Chilcott

Completed

Asacol Acute Diverticulitis(DIVA)Study

Diverticulitis

United States
Warner Chilcott

Completed

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder (HSDD)

United States, Australia, Canada
Warner Chilcott

Completed

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Warner Chilcott

Completed

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Urogential Chlamydia Trachomatis Infection

United States
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure (CORDELIA)

Heart Failure

United States
Warner Chilcott

Completed

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) (ASCEND I)

Ulcerative Colitis

United States
Mayo Clinic
Marker Therapeutics, Inc.

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Parker Institute for Cancer Immunotherapy
Seres Therapeutics, Inc.

Completed

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW)

Metastatic Melanoma

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; AstraZeneca; Sirtex Medical

Recruiting

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Cholangiocarcinoma | Bile Duct Cancer | Cholangiocarcinoma Non-resectable | Cholangiocarcinoma Metastatic | Metastatic Intrahepatic Cholangiocarcinoma

United States
Marker Therapeutics AG
Terumo BCT

Completed

Plasma Adsorption in Patients With Confirmed COVID-19

Respiratory Failure | ARDS

United States
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb

Completed

Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

Melanoma

United States
Parker Hughes Cancer Center

Unknown

Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Joon Oh Park

Recruiting

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel (MP-PDAC-01)

Metastatic Pancreatic Cancer

Korea, Republic of
Seung-Jung Park

Completed

The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries

Coronary Artery Disease | Total Occlusion of Coronary Artery

Korea, Republic of
Addario Lung Cancer Medical Institute
Dana-Farber Cancer Institute

Active, not recruiting

Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance (SPACEWALK)

Non-Small Cell Lung Cancer

United States
Charles Porter, MD
Medtronic

Completed

Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation

Heart Failure; With Decompensation

United States
Beth Israel Deaconess Medical Center

Completed

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cavity Cancer

United States
Seung-Jung Park

Recruiting

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Coronary Artery Disease

Korea, Republic of
Tel-Aviv Sourasky Medical Center
Dana-Farber Cancer Institute

Recruiting

Predicting Progression of Developing Myeloma in a High-Risk Screened Population

Healthy

Israel
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Recruiting

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Prostate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

United States
Beth Israel Deaconess Medical Center

Recruiting

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Active, not recruiting

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Completed

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Malignant Melanoma

United States
Beth Israel Deaconess Medical Center

Active, not recruiting

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

Breast Cancer

United States
Beth Israel Deaconess Medical Center

Terminated

Lenalidomide After Allo Transplant

Lymphoma | Multiple Myeloma

United States
Beth Israel Deaconess Medical Center

Withdrawn

RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Dana-Farber Cancer Institute
Tehran University of Medical Sciences

Completed

Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

Thalassemia Major

United States, Iran, Islamic Republic of
Okan University
Medical Park Hospital Istanbul

Completed

Effect of Treatment on Connective Tissue in Low Back Pain

Low Back Pain | Connective Tissue Defect (Diagnosis)

Turkey
Young Suk Park

Completed

A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types

Solid Tumors

Korea, Republic of
Medical Park Gaziantep Hospital
Harran University

Completed

A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients (SG)

Hypertension | Obesity | Diabetes | Dyslipidemia | Morbid Obesity
Seung-Jung Park

Completed

Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry

Coronary Vasospasm | Cardiac Death

Korea, Republic of
Giselle Sholler
Beat NB Cancer Foundation; Team Parker for Life

Recruiting

Neuroblastoma Maintenance Therapy Trial (NMTT)

Neuroblastoma

United States, Canada
Dana-Farber Cancer Institute
Addario Lung Cancer Medical Institute

Active, not recruiting

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT)

Lung Cancer

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Terminated

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast Cancer

United States
Beth Israel Deaconess Medical Center

Withdrawn

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Completed

In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

Malignant Melanoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center

Completed

NIR-Guided Sentinel Lymph Node Mapping in Melanoma

Melanoma

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center

Completed

Exercise Intervention in Women With Metastatic Breast Cancer

Breast Cancer

United States

Clinical Trials Sponsored by Parker Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations